The signing ceremony attended by Prime Minister Mostafa Madbouly and senior Egyptian officials. Photo by Egyptian cabinet.
PM Madbouly affirmed that the project, fully backed by President Abdel-Fattah El-Sisi, is a cornerstone of the national strategy to transfer advanced technology and localize strategic industries, particularly in the medical and pharmaceutical sectors, a statement from the Egyptian cabinet read.
It aims to meet domestic demand while expanding into export markets in neighbouring countries, capitalizing on Egypt’s capacity to drive industrial growth and build an integrated medical manufacturing hub, he added.
"The factory aims to meet 100 percent of Egypt’s annual demand for blood bags, while also boosting exports to Middle Eastern and North African markets," the Unified Procurement Authority (UPA) stated.
The facility is expected to produce seven million blood pouches annually by its seventh year — three million for local consumption and four million for export.
This would also contribute to Egypt’s medical exports and enhance foreign currency revenues.
Moreover, Madbouly emphasized that the factory’s location in Ain Sokhna was strategically chosen to benefit from government incentives and the logistical advantages offered by the SCZone, making it a competitive hub for regional and global distribution.
The project reflects Egypt’s commitment to achieving medical self-sufficiency, strengthening public-private partnerships, and attracting direct foreign investment in the pharmaceutical manufacturing sector, according to the statement.
It also comes amid growing local and international demand for high-quality blood products used in surgeries, accidents, leukaemia, kidney diseases, and organ transplants, among others.
Senior Egyptian officials attended the signing ceremony.
The agreement was signed by Osama Abdel Baset, chairman of the Egyptian Company for Medical Investments; Ahmed Sami, chairman and CEO of Interpharm Egypt for Import, Export, and Medical Industries; and Masafumi Sato, executive director of JMS Japan.
Ahmed Sami, Chairman and CEO of Interpharm Egypt for Import, Export, and Medical Industries (L), Osama Abdel Baset, Chairman of the Egyptian Company for Medical Investments (middle); and Masafumi Sato, Executive Director of JMS Japan (R). Photo by Egyptian Cabinet.
Short link: